A major breakthrough in our understanding of pain has been revealed in a collaborative study led by a Leeds scientist, ...

TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug ...

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the University of Kiel, and the Leibniz Institute of ...

A team of researchers from Weill Cornell Medicine and the Burke Neurological Institute has developed a groundbreaking drug ...

An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

Neuropathic pain, often caused by nerve damage or dysfunction, is a common side effect of certain chemotherapy drugs like ...

Scientists at Weill Cornell Medicine and the Burke Neurological Institute have developed a groundbreaking drug that may ...

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain MIAMI, FL, December 10, 2024 ...

MIRA Pharmaceuticals, Inc. , a preclinical-stage pharmaceutical company, proudly announces the successful completion of its current Good Laboratory Practice (GLP) preclinical safety program for ...

Pain is a distressing sensory and emotional sensation, which is caused by tissue injury or disease. Moreover, different disorders may cause discomfort, such as multiple sclerosis, osteoarthritis, ...